Cite
Geppe NA, Blokhin BM, Shamsheva OV, et al. Efficacy and Safety of Ergoferon in Children from 6 Months to 6 Years Old with Acute Respiratory Viral Infections in Contemporary Outpatient Practice: A Multicenter, Double-Blind, Placebo-Controlled Randomized Trial. Can Respir J. 2021;2021:5570178doi: 10.1155/2021/5570178.
Geppe, N. A., Blokhin, B. M., Shamsheva, O. V., Abdrakhmanova, S. T., Alikhanova, K. A., & Myrzabekova, G. T. (2021). Efficacy and Safety of Ergoferon in Children from 6 Months to 6 Years Old with Acute Respiratory Viral Infections in Contemporary Outpatient Practice: A Multicenter, Double-Blind, Placebo-Controlled Randomized Trial. Canadian respiratory journal, 20215570178. https://doi.org/10.1155/2021/5570178
Geppe, N A, et al. "Efficacy and Safety of Ergoferon in Children from 6 Months to 6 Years Old with Acute Respiratory Viral Infections in Contemporary Outpatient Practice: A Multicenter, Double-Blind, Placebo-Controlled Randomized Trial." Canadian respiratory journal vol. 2021 (2021): 5570178. doi: https://doi.org/10.1155/2021/5570178
Geppe NA, Blokhin BM, Shamsheva OV, Abdrakhmanova ST, Alikhanova KA, Myrzabekova GT. Efficacy and Safety of Ergoferon in Children from 6 Months to 6 Years Old with Acute Respiratory Viral Infections in Contemporary Outpatient Practice: A Multicenter, Double-Blind, Placebo-Controlled Randomized Trial. Can Respir J. 2021 Nov 15;2021:5570178. doi: 10.1155/2021/5570178. eCollection 2021. PMID: 34820034; PMCID: PMC8608533.
Copy
Download .nbib